{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T19:59:41Z","timestamp":1791662381364,"version":"4.3.4"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,10,21]],"date-time":"2022-10-21T00:00:00Z","timestamp":1666310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,10,21]],"date-time":"2022-10-21T00:00:00Z","timestamp":1666310400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The aim of this study is to evaluate whether the patient-oriented strategies encompassing individualized oocyte number (POSEIDON) criteria can reflect the prognosis of controlled ovarian stimulation (COS) by comparing the results of assisted reproductive technologies (ART) between four POSEIDON and normal responder (NR) groups. In total, 225 patients were included in this retrospective observational study. The patients underwent various COS protocols and in vitro fertilization or intracytoplasmic sperm injection, followed by fresh or frozen embryo transfer. Based on their clinical and demographic data, patients were divided into four groups according to the POSEIDON classification, and their ART outcomes were evaluated. Statistical analyses were performed using R version 4.0.5, and a p-value of\u2009&lt;\u20090.05 was considered significant. The NR group had the highest number of total oocytes retrieved and total embryos obtained, as well as the best ART outcome in terms of clinical pregnancy rate ([CPR], 47.6%). The POSEIDON groups 1 and 2 had better COS and ART outcomes than groups 3 and 4 (CPR, 22.6%, 22.1%, 16.7%, and 4.8% in groups 1\u20134, respectively); the patients in group 3 were younger than those in group 2 by definition, but their CPR was lower than that of patients in group 2. When comparing young and old women with low anti-M\u00fcllerian hormone (AMH) levels, the younger group (POSEIDON group 2) had better COS and ART outcomes than their older counterparts, especially POSEIDON group 4. A binary logistic regression adjusted for body mass index (BMI) comparing the ART outcomes of patients that did not get pregnant in the POSEIDON groups compared to the NR group showed odds ratios (ORs) (95% confidence interval) of 2.938 (1.496\u20135.768), 3.376 (1.848\u20136.167), 6.801 (2.740\u201316.881), and 20.497 (8.284\u201350.713) for groups 1, 2, 3, and 4, respectively. Ovarian reserve still seems to outweigh patients\u2019 age when predicting the ART outcomes of low-responder infertile women, as suggested by the results of POSEIDON groups 2 and 3. However, when there are no differences in ovarian reserve, as in POSEIDON groups 2 and 4, younger women with low AMH have a higher probability of pregnancy than their AMH-matched older counterparts.<\/jats:p>","DOI":"10.1038\/s41598-022-22859-w","type":"journal-article","created":{"date-parts":[[2022,10,21]],"date-time":"2022-10-21T20:23:48Z","timestamp":1666383828000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Comparison of ART outcome in patients with poor ovarian response according to POSEIDON criteria"],"prefix":"10.1038","volume":"12","author":[{"given":"Hyun Joo","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hye Kyung","family":"Noh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong Kil","family":"Joo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,21]]},"reference":[{"key":"22859_CR1","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.bpobgyn.2020.06.012","volume":"70","author":"S Seshadri","year":"2021","unstructured":"Seshadri, S., Morris, G., Serhal, P. & Saab, W. Assisted conception in women of advanced maternal age. Best Pract. Res. Clin. Obstet. Gynaecol. 70, 10\u201320 (2021).","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"issue":"6","key":"22859_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/0300060520934656","volume":"48","author":"L-N Yao","year":"2020","unstructured":"Yao, L.-N. et al. Comparative study of assisted reproductive outcomes between young patients with occult premature ovarian insufficiency and advanced-age patients. J. Int. Med. Res. 48(6), 1\u201310 (2020).","journal-title":"J. Int. Med. Res."},{"issue":"10","key":"22859_CR3","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1093\/humrep\/deaa188","volume":"35","author":"MW Christensen","year":"2020","unstructured":"Christensen, M. W., Kesmodel, U. S., Christensen, K., Kirkegaard, K. & Ingerslev, H. J. Early ovarian ageing: Is a low number of oocytes harvested in young women associated with an earlier and increased risk of age-related diseases?. Hum. Reprod. 35(10), 2375\u20132390 (2020).","journal-title":"Hum. Reprod."},{"issue":"6","key":"22859_CR4","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.3390\/ijms21062110","volume":"21","author":"A Abu-Musa","year":"2020","unstructured":"Abu-Musa, A., Haahr, T. & Humaidan, P. Novel physiology and definition of poor ovarian response; clinical recommendations. Int. J. Mol. Sci. 21(6), 2110 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"22859_CR5","doi-asserted-by":"publisher","first-page":"461","DOI":"10.3389\/fendo.2018.00461","volume":"9","author":"SC Esteves","year":"2018","unstructured":"Esteves, S. C. et al. Defining low prognosis patients undergoing assisted reproductive technology: POSEIDON criteria\u2014The why. Front. Endocrinol. 9, 461 (2018).","journal-title":"Front. Endocrinol."},{"issue":"7","key":"22859_CR6","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1093\/humrep\/der092","volume":"26","author":"AP Ferraretti","year":"2011","unstructured":"Ferraretti, A. P. et al. ESHRE consensus on the definition of \u2018poor response\u2019 to ovarian stimulation for in vitro fertilization: The Bologna criteria\u2020. Hum. Reprod. 26(7), 1616\u20131624 (2011).","journal-title":"Hum. Reprod."},{"key":"22859_CR7","doi-asserted-by":"publisher","first-page":"589","DOI":"10.3389\/fendo.2018.00589","volume":"9","author":"C Alviggi","year":"2018","unstructured":"Alviggi, C. et al. Understanding ovarian hypo-response to exogenous gonadotropin in ovarian stimulation and its new proposed marker\u2014The Follicle-To-Oocyte (FOI) Index. Front. Endocrinol. 9, 589 (2018).","journal-title":"Front. Endocrinol."},{"issue":"6","key":"22859_CR8","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1016\/j.fertnstert.2016.02.005","volume":"105","author":"C Alviggi","year":"2016","unstructured":"Alviggi, C. et al. A new more detailed stratification of low responders to ovarian stimulation: From a poor ovarian response to a low prognosis concept. Fertil. Steril. 105(6), 1452\u20131453 (2016).","journal-title":"Fertil. Steril."},{"key":"22859_CR9","doi-asserted-by":"publisher","first-page":"814","DOI":"10.3389\/fendo.2019.00814","volume":"10","author":"SC Esteves","year":"2019","unstructured":"Esteves, S. C. et al. The POSEIDON criteria and its measure of success through the eyes of clinicians and embryologists. Front. Endocrinol. 10, 814 (2019).","journal-title":"Front. Endocrinol."},{"key":"22859_CR10","doi-asserted-by":"publisher","first-page":"181","DOI":"10.3389\/fendo.2020.00181","volume":"11","author":"L Chen","year":"2020","unstructured":"Chen, L. et al. Follicular output rate and follicle-to-oocyte index of low prognosis patients according to POSEIDON criteria: A retrospective cohort study of 32,128 treatment cycles. Front. Endocrinol. 11, 181 (2020).","journal-title":"Front. Endocrinol."},{"issue":"7","key":"22859_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jogoh.2020.101817","volume":"49","author":"B Seven","year":"2020","unstructured":"Seven, B., Gulerman, C., Ozgu-Erdinc, A. S., Yilmaz, N. & Engin-Ustun, Y. Live birth rates of low prognosis patients according to POSEIDON criteria; A retrospective cohort study. J. Gynecol. Obstet. Hum. Reprod. 49(7), 101817 (2020).","journal-title":"J. Gynecol. Obstet. Hum. Reprod."},{"key":"22859_CR12","doi-asserted-by":"publisher","first-page":"282","DOI":"10.3389\/fendo.2019.00282","volume":"10","author":"PE Levi-Setti","year":"2019","unstructured":"Levi-Setti, P. E. et al. An observational retrospective cohort trial on 4,828 IVF cycles evaluating different low prognosis patients following the POSEIDON criteria. Front. Endocrinol. 10, 282 (2019).","journal-title":"Front. Endocrinol."},{"issue":"4","key":"22859_CR13","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.mefs.2018.06.002","volume":"23","author":"M Eftekhar","year":"2018","unstructured":"Eftekhar, M., Mirhashemi, E. S. & Tabibnejad, N. Outcome of assisted reproductive technology in different subgroups of poor ovarian responders fulfilling the POSEIDON criteria. Middle East Fertil. Soc. J. 23(4), 399\u2013403 (2018).","journal-title":"Middle East Fertil. Soc. J."},{"key":"22859_CR14","doi-asserted-by":"publisher","first-page":"409","DOI":"10.3389\/fendo.2019.00409","volume":"10","author":"W Shi","year":"2019","unstructured":"Shi, W. et al. Cumulative live birth rates of good and low prognosis patients according to POSEIDON criteria: A single center analysis of 18,455 treatment cycles. Front. Endocrinol. 10, 409 (2019).","journal-title":"Front. Endocrinol."},{"issue":"2","key":"22859_CR15","doi-asserted-by":"publisher","first-page":"135","DOI":"10.5653\/cerm.2019.03349","volume":"47","author":"SJ Kim","year":"2020","unstructured":"Kim, S. J., Lee, D., Kim, S. K., Jee, B. C. & Kim, S. H. Cumulative live birth rate after up to three consecutive embryo transfer cycles in women with poor ovarian response. Clin. Exp. Reprod. Med. 47(2), 135\u2013139 (2020).","journal-title":"Clin. Exp. Reprod. Med."},{"issue":"1","key":"22859_CR16","doi-asserted-by":"publisher","first-page":"hoaa070","DOI":"10.1093\/hropen\/hoaa070","volume":"2021","author":"P Chinta","year":"2021","unstructured":"Chinta, P., Antonisamy, B., Mangalaraj, A. M., Kunjummen, A. T. & Kamath, M. S. POSEIDON classification and the proposed treatment options for groups 1 and 2: Time to revisit? A retrospective analysis of 1425 ART cycles. Hum. Reprod. Open. 2021(1), hoaa070 (2021).","journal-title":"Hum. Reprod. Open."},{"issue":"1","key":"22859_CR17","doi-asserted-by":"publisher","first-page":"11822","DOI":"10.1038\/s41598-020-68896-1","volume":"10","author":"RK Abdullah","year":"2020","unstructured":"Abdullah, R. K. et al. Cumulative live-birth, perinatal and obstetric outcomes for POSEIDON groups after IVF\/ICSI cycles: A single-center retrospective study. Sci. Rep. 10(1), 11822 (2020).","journal-title":"Sci. Rep."},{"issue":"1","key":"22859_CR18","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s43032-020-00249-9","volume":"28","author":"M Awadalla","year":"2021","unstructured":"Awadalla, M., Vestal, N., McGinnis, L. & Ahmady, A. Effect of age and morphology on live birth rate after cleavage stage embryo transfer. Reprod. Sci. 28(1), 43\u201351 (2021).","journal-title":"Reprod. Sci."},{"issue":"1","key":"22859_CR19","doi-asserted-by":"publisher","first-page":"10800","DOI":"10.1038\/s41598-021-90254-y","volume":"11","author":"MS Awadalla","year":"2021","unstructured":"Awadalla, M. S., Bendikson, K. A., Ho, J. R., McGinnis, L. K. & Ahmady, A. A validated model for predicting live birth after embryo transfer. Sci. Rep. 11(1), 10800 (2021).","journal-title":"Sci. Rep."},{"issue":"6","key":"22859_CR20","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1007\/s10815-013-9991-3","volume":"30","author":"Y Tokura","year":"2013","unstructured":"Tokura, Y. et al. The significance of serum anti-M\u00fcllerian hormone (AMH) levels in patients over age 40 in first IVF treatment. J. Assist. Reprod. Genet. 30(6), 821\u2013825 (2013).","journal-title":"J. Assist. Reprod. Genet."},{"key":"22859_CR21","doi-asserted-by":"crossref","first-page":"263349412094148","DOI":"10.1177\/2633494120941480","volume":"14","author":"P Drakopoulos","year":"2020","unstructured":"Drakopoulos, P. et al. Update on the management of poor ovarian response in IVF: The shift from Bologna criteria to the Poseidon concept. Ther. Adv. Reprod. Health. 14, 2633494120941480 (2020).","journal-title":"Ther. Adv. Reprod. Health."},{"issue":"1","key":"22859_CR22","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1093\/humupd\/dmt037","volume":"20","author":"A La Marca","year":"2013","unstructured":"La Marca, A. & Sunkara, S. K. Individualization of controlled ovarian stimulation in IVF using ovarian reserve markers: From theory to practice. Hum. Reprod. Update 20(1), 124\u2013140 (2013).","journal-title":"Hum. Reprod. Update"},{"key":"22859_CR23","doi-asserted-by":"publisher","first-page":"192","DOI":"10.3389\/fendo.2020.00192","volume":"11","author":"Z Blumenfeld","year":"2020","unstructured":"Blumenfeld, Z. What is the best regimen for ovarian stimulation of poor responders in ART\/IVF?. Front. Endocrinol. 11, 192 (2020).","journal-title":"Front. Endocrinol."},{"issue":"5","key":"22859_CR24","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1093\/humupd\/dmx017","volume":"23","author":"CB Lambalk","year":"2017","unstructured":"Lambalk, C. B. et al. GnRH antagonist versus long agonist protocols in IVF: A systematic review and meta-analysis accounting for patient type. Hum. Reprod. Update 23(5), 560\u2013579 (2017).","journal-title":"Hum. Reprod. Update"},{"issue":"2","key":"22859_CR25","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1530\/jrf.0.0760771","volume":"76","author":"AA Templeton","year":"1986","unstructured":"Templeton, A. A. et al. Oocyte recovery and fertilization rates in women at various times after the administration of hCG. Reproduction 76(2), 771\u2013778 (1986).","journal-title":"Reproduction"},{"issue":"2","key":"22859_CR26","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1056\/NEJMoa1705334","volume":"378","author":"Y Shi","year":"2018","unstructured":"Shi, Y. et al. Transfer of fresh versus frozen embryos in ovulatory women. N. Engl. J. Med. 378(2), 126\u2013136 (2018).","journal-title":"N. Engl. J. Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-22859-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-22859-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-22859-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,21]],"date-time":"2022-10-21T20:26:35Z","timestamp":1666383995000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-22859-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,21]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["22859"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-22859-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,21]]},"assertion":[{"value":"2 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"17723"}}